Predicting iPFS and EGFR-TKI Efficacy in EGFR-Mutated Lung Adenocarcinoma with Brain Metastases
The following is a summary of “Clinical characteristics and MRI-based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases,” published in the March 2024 issue of …